This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2025
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2025 | 990 | $9,251,199 | $7,373,338 | $620,294 | $17,464,989 | $13,714,117 |
| FY2024 | 990 | $8,276,217 | $9,009,001 | $784,888 | $15,320,155 | $11,454,714 |
| FY2023 | 990 | $11,816,537 | $10,341,815 | $562,831 | $16,794,445 | $11,735,249 |
| FY2022 | 990 | $11,007,903 | $9,685,619 | $319,696 | $17,064,469 | $9,975,006 |
| FY2021 | 990 | $8,965,595 | $8,341,845 | $302,895 | $14,745,592 | $9,312,283 |
| FY2020 | 990 | $10,702,044 | $11,291,623 | $342,863 | $10,892,804 | $7,297,830 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 91% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAPHILADELPHIA, PA | NANOTECHNOLOGY TARGETING OF ALVEOLAR EPITHELIAL PROTEOSTASIS IN PULMONARY FIBROSIS | $125,000 | 2024 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Scott Staszak | PRESIDENT & CEO | 40.00 | $421,578 |
| Franck Rahaghi | FORMER PRESIDENT & CEO | 40.00 | $284,230 |
| Seth Klein | CHIEF DEVELOPMENT OFFICER | 40.00 | $209,028 |
| Jessica Shore | SR. VP, CLINICAL AFFAIRS AND QUALITY |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKNEW YORK, NY |
| INVESTIGATION OF KIF15 AS A NOVEL FAMILIAL PULMONARY FIBROSIS GENE |
| $125,000 |
| 2024 |
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKNEW YORK, NY | INVESTIGATION OF KIF15 AS A NOVEL FAMILIAL PULMONARY FIBROSIS GENE | $122,500 | 2023 |
| THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAPHILADELPHIA, PA | NANOTECHNOLOGY TARGETING OF ALVEOLAR EPITHELIAL PROTEOSTASIS IN PULMONARY FIBROSIS | $122,500 | 2023 |
| THE REGENTS OF THE UNIVERSITY OF MICHIGANANN ARBOR, MI | ROLE OF NON-CANONICAL AHR SIGNALING IN CORONAVIRUS EXACERBATIONS OF PULMONARY FIBROSIS | $100,000 | 2024 |
| CEDARS-SINAI MEDICAL CENTERLOS ANGELES, CA | REGULATION OF HER2 ACTIVATION IN FIBROBLAST INVASION AND PULMONARY FIBROSIS. | $100,000 | 2025 |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITYNEW YORK, NY | ASSOCIATIONS OF CT-ASSESSED AIRWAY DIAMETER AND CLINICAL OUTCOMES IN PULMONARY FIBROSIS | $100,000 | 2025 |
| UNIVERSITY OF WISCONSIN-MADISONMADISON, WI | FIBRONECTIN-TARGETING PEPTIDE AS A PET-BASED PROBE FOR ACTIVE PULMONARY FIBROSIS | $100,000 | 2024 |
| THE RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIACHARLOTTESVILLE, VA | THE ROLE OF B-1 CELLS AND IGM IN PULMONARY FIBROSIS PATHOGENSIS | $100,000 | 2025 |
| VANDERBILT UNIVERSITY MEDICAL CENTERNASHVILLE, TN | HIF2 MODULATION OF ALVEOLAR REPAIR IN PULMONARY FIBROSIS | $100,000 | 2025 |
| UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTEKANSAS CITY, KS | METABOLOMICS OF PRECLINICAL PULMONARY FIBROSIS | $100,000 | 2025 |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINEBALTIMORE, MD | UNDERSTANDING CURRENT ATTITUDES TOWARD ADVANCE CARE PLANNING AND EVALUATION OF THE IMPACT OF AN EDUCATIONAL TOOL IN PATIENTS WITH PULMONARY FIBROSIS | $100,000 | 2024 |
| THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYREDWOOD, CA | TERT EXPRESSING ALVEOLAR TYPE II CELLS AS UNIPOTENT PROGENITORS WITH EXPANDED PROLIFERATIVE CAPACITIES | $100,000 | 2024 |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINEBALTIMORE, MD | PULMONARY HYPERTENSION PREDICTION IN PATIENTS WITH INTERSTITIAL LUNG DISEASE | $100,000 | 2025 |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLA JOLLA, CA | CHARACTERIZATION OF PHENOTYPIC PLASTICITY OF IPF ALVEOLAR EPITHELIAL TYPE II CELLS | $100,000 | 2024 |
| UNIVERSITY OF CHICAGOCHICAGO, IL | IDENTIFYING THE IMPACT OF WORKPLACE EXPOSURES ON QUALITY OF LIFE, LUNG FUNCTION, AND SURVIVAL ACROSS INTERSTITIAL LUNG DISEASE | $75,000 | 2023 |
| University of California San FranciscoSan Francisco, CA | See Part IV | $75,000 | 2022 |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCOSAN FRANCISCO, CA | DEVELOPMENT OF A TELEHEALTH INTERVENTION TARGETING BARRIERS TO EARLY GUIDELINE-CONCORDANT IDIOPATHIC PULMONARY FIBROSIS CARE FOR RURAL POPULATIONS | $75,000 | 2023 |
| Virginia Commonwealth UniversityRichmond, VA | See Part IV | $75,000 | 2022 |
| National Jewish HealthDenver, CO | See Part IV | $75,000 | 2022 |
| YALE UNIVERSITYNEW HAVEN, CT | NEURO-INNATE INTERACTIONS IN PULMONARY FIBROSIS | $75,000 | 2023 |
| Virginia Commonwealth UniversityRichmond, VA | See Part IV | $75,000 | 2022 |
| THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAPHILADELPHIA, PA | METABOLIC DYSFUNCTION AND EPIGENETIC REPROGRAMMING IN DISTAL ALVEOLAR EPITHELIAL PROGENITOR CELL FUNCTION AND IPF | $75,000 | 2023 |
| Vanderbilt University Medical CenterNashville, TN | See Part IV | $50,000 | 2021 |
| Mayo ClinicRochester, MN | See Part IV | $50,000 | 2020 |
| 40.00 |
| $202,398 |
| Janet Bianchetta | CHIEF FINANCIAL OFFICER | 40.00 | $184,343 |
| Katherine Bein | VP, ADVOCACY AND PROGRAMS | 40.00 | $158,916 |
| Jennifer Mefford | VP, CORPORATE PARTNERSHIPS | 40.00 | $172,561 |
| Zoe Bubany | VP, BOARD AND EXTERNAL RELATIONS | 40.00 | $141,984 |
| Amy Wardzala | VP, DEVELOPMENT | 40.00 | $132,201 |
| Wayne Pan Md Phd Mba | CHAIR | 1.00 | $0 |
| Patricia Rosa | VICE CHAIR | 1.00 | $0 |
| Martin Attwell | SECRETARY | 1.00 | $0 |
| Laurie Chandler Cfp | TREASURER | 1.00 | $0 |
| Grant Ballantyne | DIRECTOR | 1.00 | $0 |
| Harold R Collard Md | DIRECTOR | 1.00 | $0 |
| Terence Hales | DIRECTOR | 1.00 | $0 |
| Julie Halston | DIRECTOR | 1.00 | $0 |
| Jeff Harris | DIRECTOR | 1.00 | $0 |
| Susan Jacobs Rn Ms | DIRECTOR | 1.00 | $0 |
| Heather Kagel | DIRECTOR | 1.00 | $0 |
| Pj Kamani | DIRECTOR | 1.00 | $0 |
| Devi Kumar-Nambiar Jd Mba | DIRECTOR | 1.00 | $0 |
| David Mcninch | DIRECTOR | 1.00 | $0 |
| William Schmidt | DIRECTOR | 1.00 | $0 |
| Kenneth Fang Md | DIRECTOR - TERM | 1.00 | $0 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2024 · period ending Jun 30, 2024IRS bulk XML
Filing id 202540809349301619
Form 990 · FY2023 · period ending Jun 30, 2023IRS bulk XML
Filing id 202411029349300201
Form 990 · FY2022 · period ending Jun 30, 2022
Filing id 202320909349301012
Form 990 · FY2021 · period ending Jun 30, 2021
Filing id 202241159349301359
Form 990 · FY2020 · period ending Jun 30, 2020
Filing id 202121059349301127
Form 990 · FY2019 · period ending Jun 30, 2019
Filing id 202020519349301007
Form 990 · FY2018 · period ending Jun 30, 2018
Filing id 201910449349301411
Form 990 · FY2017 · period ending Jun 30, 2017
Filing id 201831319349301668
Form 990 · FY2016 · period ending Jun 30, 2016
Filing id 201721259349300342
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.